Back to today’s briefing

Story perspectives

Tempus AI Acquires Paige for $81M, Boosting Oncology

8/23/2025

50 3

Summary

Story summary

Tempus AI is acquiring Paige, a digital pathology company, for $81.25 million to enhance oncology capabilities.
The acquisition will create the largest AI foundation model in oncology, improving cancer detection and treatment.
Tempus reported Q2 2025 revenue of $314.6 million, nearly doubling year-over-year.
Increased stakes from institutional investors indicate confidence in Tempus' long-term potential in AI-driven healthcare.

1 of 1

Story summary

Tempus AI is acquiring Paige, a digital pathology company, for $81.25 million to enhance oncology capabilities.
The acquisition will create the largest AI foundation model in oncology, improving cancer detection and treatment.
Tempus reported Q2 2025 revenue of $314.6 million, nearly doubling year-over-year.
Increased stakes from institutional investors indicate confidence in Tempus' long-term potential in AI-driven healthcare.